![Thomas J. Brya](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Thomas J.
Brya was the founder who founded GeneriCo LLC in 2013 and served as President & Chief Executive Officer.
He also held former positions as Chairman at Arch Oncology, Inc., Vice President & General Manager at Cardinal Health, Inc., Senior Vice President-Corporate Development at AMAG Pharma USA, Inc., Vice President at Global Therapeutics, Inc., and Senior Vice President-Business Development at ABIONYX Pharma SA. Mr. Brya's education history includes an undergraduate degree from Benedictine University in 1981, an MBA from Northwestern University in 2004, and a graduate degree from DePaul University in 1987.
Former positions of Thomas J. Brya
Companies | Position | End |
---|---|---|
GeneriCo LLC
![]() GeneriCo LLC Pharmaceuticals: GenericHealth Technology GeneriCo LLC develops and markets generic drugs. The firm also has an embedded drug delivery technology, which used to make generic drugs to the targeted markets. Its products include pipeline and therapeutic areas. The company was founded by Thomas J. Brya, Michael Grimshaw, and Shu Zhu in 2013 and is headquartered in St. Louis, MO. | Chief Executive Officer | - |
Global Therapeutics, Inc. | Corporate Officer/Principal | - |
AMAG Pharma USA, Inc.
![]() AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Arch Oncology, Inc.
![]() Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Chairman | - |
CARDINAL HEALTH, INC. | Corporate Officer/Principal | - |
Training of Thomas J. Brya
Benedictine University | Undergraduate Degree |
Northwestern University | Masters Business Admin |
DePaul University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
CARDINAL HEALTH, INC. | Distribution Services |
ABIONYX PHARMA | Health Technology |
Private companies | 4 |
---|---|
AMAG Pharma USA, Inc.
![]() AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Health Technology |
GeneriCo LLC
![]() GeneriCo LLC Pharmaceuticals: GenericHealth Technology GeneriCo LLC develops and markets generic drugs. The firm also has an embedded drug delivery technology, which used to make generic drugs to the targeted markets. Its products include pipeline and therapeutic areas. The company was founded by Thomas J. Brya, Michael Grimshaw, and Shu Zhu in 2013 and is headquartered in St. Louis, MO. | Health Technology |
Global Therapeutics, Inc. | Commercial Services |
Arch Oncology, Inc.
![]() Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Commercial Services |
- Stock Market
- Insiders
- Thomas J. Brya